Skip to main content
. Author manuscript; available in PMC: 2017 Aug 1.
Published in final edited form as: Biomaterials. 2016 Apr 26;98:1–22. doi: 10.1016/j.biomaterials.2016.04.018

Table 4.

Cell expansion medium composition (blank entries indicate the information was not available to the authors). The last column represents additional supplements that were added to the existing expansion medium to formulate the medium used for 3D culture. Cell passage numbers are indicated in Table 1.

Product Base Medium Serum Antibiotics Growth Factors Ascorbate Other
Additives
3D Culture
BiocartII Autologous serum FGF-2 variant (10
ng/mL)
Bioseed-C Autologous serum
Cartipatch® DMEM/Ham’s
F-12 (1:1)
10% autologous
serum
Gentamycin
fungizone
(discontinued
after P1
50 μg/mL
Chondrosphere® DMEM/Ham’s
F-12 (1:1)
Autologous serum None None
Hyalograft® C Ham’s F-12 10% FCS Penicillin
streptomycin
TGF-B1 (1ng/mL),
FGF-2 (5ng/mL),
EGF (1ng/mL)
1 ng/mL insulin
1% L-glutamine
+ 50 mg/mL
ascorbic acid
MACI DMEM 9% FBS Gentamycin
NeoCart®
NOVOCART® 3D Allogeneic serum None
RevaFlex HL-1 or similar 10% serum to
serum-free
Yes 50 μg/mL